Specifications include, but are not limited to: The University of Missouri-St. Louis desires to purchase NARCAN (Naloxone HCI) Nasal Spray for distribution through the Missouri State Targeted Response to the Opioid Crisis (STR) Grant, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA). The STR grant recipient is the Missouri Department of Mental Health (DMH). DMH contracts the University of Missouri, St. Louis (UMSL) – Missouri Institute of Mental Health (MIMH) to administer, implement, and evaluate the STR grant. The goals of the STR grant span the domains of opioid use disorder prevention, treatment, and recovery support. A large component of the STR grant includes the provision of training and support for overdose education and naloxone distribution (OEND) efforts. The STR grant team provides OEND training to entities working with a variety of populations, including those reentering communities after incarceration, those seeking services at local recovery community centers, and those residing in sober living facilities. UMSL-MIMH will be purchasing upwards of 10,000 boxes of Narcan nasal spray to distribute to organizations and entities working with these populations and others. UMSL-MIMH already maintains a standing order for these purchases, signed by Dr. Angeline Stanislaus, Medical Director of Adult Treatment for the State of Missouri, with DMH. The UMSL-MIMH team is aware of, and compliant with, all processes required for the purchase and distribution of Narcan nasal spray.